Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule Washington, D.C. (September 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Trump Administration’s Final Rule issued today on the importation of prescription drugs: “With 40…

[...]
Man presenting on video

Maine submitted a state importation plan to the U.S. Department of Health and Human Services (HHS) recently to meet its own May 1, 2020 deadline. Given the deep structural flaws in both the idea of importing medicine from Canada and in Maine’s application to do so, PSM wonders if there is a better use of Maine taxpayer dollars than to continue to pursue this idea.

[...]

In June 2019, the governor of Maine signed into law LD 1272, a bill that would allow the state to establish a wholesale Canadian prescription drug importation program. On April 13, 2020, the Partnership for Safe Medicines (PSM) filed a request to receive copies of all submitted responses to Maine’s Request for Comment (RFC) for…

[...]

Yesterday ended a 78-day comment period for the White House’s proposal to import medicine from Canada. In all, over 1,000 comments were filed. Overwhelmingly, these comments opposed the proposed rule or expressed skepticism that the rule could meet the two requirements listed in the Medicare Modernization Act of 2003: be safe and save consumers money. In fact, when you read the comments, it is clear that this policy is overwhelming opposed by experts on the issues of economics and medicine safety.

[...]